Diagnostic performance of PET myocardial perfusion imaging with Flurpiridaz F18 is unaffected by cardiac size and is superior to SPECT in patients with smaller left ventricles: a sub-study of the Flurpiridaz F18 phase III clinical trial
JOURNAL OF NUCLEAR MEDICINE（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要